BIO-TECHNE Corp - Common Stock (TECH)

CUSIP: 09073M104

Q1 2026 13F Holders as of 31 Mar 2026

Type / Class
Equity / Common Stock
Shares outstanding
156,633,753
Total 13F shares
7,966,359
Share change
-889,946
Total reported value
$416,456,185
Price per share
$52.26
Number of holders
175
Value change
-$50,102,595
Number of buys
68
Number of sells
90

Quarterly Holders Quick Answers

What is CUSIP 09073M104?
CUSIP 09073M104 identifies TECH - BIO-TECHNE Corp - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of TECH - BIO-TECHNE Corp - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
VANGUARD GROUP INC
13F
Company
11%
17,810,878
$1,047,457,735 31 Dec 2025
13F
BlackRock, Inc.
13F 13D/G
Company
7%
from 13D/G
12,129,125
$713,313,819 31 Dec 2025
VANGUARD CAPITAL MANAGEMENT LLC
13D/G
Vanguard Capital Management
7.4%
11,559,571
$604,103,180 $0 31 Mar 2026
MORGAN STANLEY
13F
Company
5.3%
8,345,414
$490,794,044 31 Dec 2025
13F
STATE STREET CORP
13F
Company
3.7%
5,812,032
$341,805,602 31 Dec 2025
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
3.7%
5,734,049
$337,219,422 31 Dec 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
3.1%
4,929,801
$289,502,286 31 Dec 2025
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F 13D/G
Company · T. Rowe Price Associates, Inc.
2.2%
from 13D/G
4,075,194
$239,663,000 31 Dec 2025
MASSACHUSETTS FINANCIAL SERVICES CO /MA/
13F
Company
2.6%
4,012,818
$235,993,825 31 Dec 2025
13F
MAVERICK CAPITAL LTD
13F
Company
2.5%
3,850,923
$226,472,782 31 Dec 2025
13F
Invesco Ltd.
13F
Company
2.3%
3,678,659
$216,341,937 31 Dec 2025
13F
Neuberger Berman Group LLC
13F
Company
2%
3,129,334
$184,036,113 31 Dec 2025
13F
Select Equity Group, L.P.
13F
Company
1.8%
2,837,142
$166,852,321 31 Dec 2025
13F
AMERIPRISE FINANCIAL INC
13F
Company
1.8%
2,798,437
$164,576,211 31 Dec 2025
13F
MAIRS & POWER INC
13F
Company
1.8%
2,767,539
$162,758,957 31 Dec 2025
13F
DF DENT & CO INC
13F
Company
1.7%
2,592,215
$152,448,149 31 Dec 2025
13F
MACKENZIE FINANCIAL CORP
13F
Company
1.5%
2,414,165
$142,444,643 31 Dec 2025
13F
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC
13F
Company
1.5%
2,398,265
$141,041,965 31 Dec 2025
13F
Sumitomo Mitsui Trust Group, Inc.
13F
Company
1.5%
2,368,162
$139,271,607 31 Dec 2025
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
1.5%
2,364,845
$139,076,534 31 Dec 2025
13F
UBS Group AG
13F
Company
1.4%
2,224,263
$130,808,907 31 Dec 2025
13F
RGM Capital, LLC
13F
Company
1.4%
2,152,052
$126,562,178 31 Dec 2025
13F
Durable Capital Partners LP
13F
Company
1.3%
2,088,891
$122,847,680 31 Dec 2025
13F
AMERICAN CENTURY COMPANIES INC
13F
Company
1.2%
1,928,485
$113,414,203 31 Dec 2025
13F
SNYDER CAPITAL MANAGEMENT L P
13F
Company
1.2%
1,926,866
$113,318,989 31 Dec 2025
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
1.1%
1,794,293
$105,523,778 31 Dec 2025
13F
Bank of New York Mellon Corp
13F
Company
1.1%
1,790,687
$105,310,252 31 Dec 2025
13F
NOMURA ASSET MANAGEMENT INTERNATIONAL INC.
13F
Company
1.1%
1,774,947
$104,385,000 31 Dec 2025
13F
Charles R. Kummeth
3/4/5
Chief Executive Officer, Director
mixed-class rows
1,938,164
mixed-class rows
$103,771,891 15 Aug 2023
GOLDMAN SACHS GROUP INC
13F
Company
1.1%
1,692,842
$99,556,044 31 Dec 2025
13F
NORGES BANK
13F
Company
1.1%
1,691,780
$99,493,582 31 Dec 2025
13F
Capital Research Global Investors
13F
Company
1%
1,618,882
$95,206,450 31 Dec 2025
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
1%
1,559,144
$91,693,259 31 Dec 2025
13F
BROWN ADVISORY INC
13F
Company
0.99%
1,544,528
$90,833,688 31 Dec 2025
13F
Ruane, Cunniff & Goldfarb L.P.
13F
Company
0.94%
1,465,935
$86,211,637 31 Dec 2025
13F
Champlain Investment Partners, LLC
13F
Company
0.9%
1,403,769
$82,555,655 31 Dec 2025
13F
NORTHERN TRUST CORP
13F
Company
0.85%
1,332,200
$78,346,682 31 Dec 2025
13F
BAMCO INC /NY/
13F
Company
0.77%
1,207,499
$71,013,016 31 Dec 2025
13F
Madison Asset Management, LLC
13F
Company
0.75%
1,181,308
$69,472,749 31 Dec 2025
13F
SG Capital Management LLC
13F
Company
0.73%
1,149,129
$67,580,276 31 Dec 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.73%
1,137,315
$66,885,517 31 Dec 2025
13F
Stephens Investment Management Group LLC
13F
Company
0.71%
1,109,658
$65,258,987 31 Dec 2025
13F
GENEVA CAPITAL MANAGEMENT LLC
13F
Company
0.7%
1,090,495
$64,132,012 31 Dec 2025
13F
Quantinno Capital Management LP
13F
Company
0.65%
1,019,342
$59,947,524 31 Dec 2025
13F
FMR LLC
13F
Company
0.65%
1,014,961
$59,689,871 31 Dec 2025
13F
WESTFIELD CAPITAL MANAGEMENT CO LP
13F
Company
0.63%
994,330
$58,476,547 31 Dec 2025
13F
T. Rowe Price Investment Management, Inc.
13F
Company
0.63%
979,402
$57,599,000 31 Dec 2025
13F
Clearbridge Investments, LLC
13F
Company
0.61%
948,512
$55,782,010 31 Dec 2025
13F
AMERICAN CAPITAL MANAGEMENT INC
13F
Company
0.6%
941,149
$55,348,973 31 Dec 2025
13F
SCHRODER INVESTMENT MANAGEMENT GROUP
13F
Company
0.55%
863,790
$51,067,265 31 Dec 2025
13F

Institutional Holders of BIO-TECHNE Corp - Common Stock (TECH) as of Q1 2026

As of 31 Mar 2026, BIO-TECHNE Corp - Common Stock (TECH) was held by 175 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,966,359 shares. The largest 10 holders included Sumitomo Mitsui Trust Group, Inc., Stephens Investment Management Group LLC, RIVERBRIDGE PARTNERS LLC, Border to Coast Pensions Partnership Ltd, Conestoga Capital Advisors, LLC, Nuveen, LLC, FORT WASHINGTON INVESTMENT ADVISORS INC /OH/, BI Asset Management Fondsmaeglerselskab A/S, Thrivent Financial for Lutherans, and HSBC HOLDINGS PLC. This page lists 178 institutional shareholders reporting positions in this security for the Q1 2026 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2026 vs Q4 2025 Across Filers

Q4 2025 holders
578
Q1 2026 holders
175
Holder diff
-403
Investor Q4 2025 Shares Q1 2026 Shares Share Diff Share Chg % Q4 2025 Value $ Q1 2026 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .